盐替代对中老年高血压患者心脏结构和心电图参数的影响
Li Che1, Ying Zhang2, Xia Chen3
1Department of Cardiology, Central Hospital of Dalian University of Technology, 116033 Dalian, Liaoning, China.
Reviews in cardiovascular medicine
|December 2, 2024
概括
盐替代 (SS) 在高血压患者中显著改善心脏结构和心电图 (ECG) 参数. 这种干预减少了左心脏直径 (LAD) 和左心室质量 (LVM),提供了潜在的心脏风险管理益处.
科学领域:
- 心脏病学 心脏病学
- 高血压管理 高血压管理
- 心血管研究研究心血管研究
背景情况:
- 已知盐替代 (SS) 可以降低血压 (BP).
- 对于SS对心脏结构和心电图参数的影响尚不清楚.
- 高血压带来了相当大的心血管风险.
研究的目的:
- 用超声波心脏图 (UCG) 来评估盐替代对心脏结构的影响.
- 评估盐替代对心电图 (ECG) 参数的影响.
- 研究SS在高血压患者心脏风险管理中的作用.
主要方法:
- 这是一项为期12个月的多中心随机双盲研究.
- 涉及352名高血压患者,年龄在50-70岁之间.
- 将正常盐 (NS) 与盐替代 (SS) 组进行比较,测量BP,UCG和ECG参数.
主要成果:
- 与正常盐相比,盐替代显著降低了静缩和静缩血压.
- SS导致左心脏直径 (LAD) 和左心室质量 (LVM) 的显著减少.
- 在UCG参数中观察到改善,包括QT分散 (QTd),Tp-e和Tp-e/QT.
结论:
- 在高血压患者中,盐替代有效改善心脏结构 (LAD,LVM).
- 低频率对关键的心电图参数 (QTd,Tp-e,Tp-e/QT) 有积极的影响.
- 低血压是一种有前途的干预措施,可以缓解与高血压相关的心脏风险.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
Heart Failure Drugs: Diuretics
340
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
340
Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Antihypertensive Drugs: Potassium-Sparing Diuretics
455
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
455
Mitral Regurgitation IV: Nursing Management
2
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
2


